BiotechTube
Home/ADC Therapeutics/Joseph Camardo
JC

Joseph Camardo

Chief Medical Officer

ADC Therapeutics

Therapeutic Areas

OncologyHematology

ADC Therapeutics Pipeline

DrugIndicationPhase
ZYNLONTA® (loncastuximab tesirine-lpyl)Relapsed/Refractory DLBCLApproved
ZYNLONTA® combinationsEarlier lines of DLBCLPhase 3
ZYNLONTA®Indolent Non-Hodgkin LymphomasPhase 2
ADCT-601Advanced Solid TumorsPhase 1/2
ADCT-901Advanced Solid TumorsPhase 1

Leadership Team at ADC Therapeutics

AM
Ameet Mallik
Chief Executive Officer
PG
Peter Graham
Chief Legal Officer
DE
David Ege
Chief Technical Officer
KP
Kimberly Pope
Senior Vice President, Human Resources
VS
Victor Sandor
Non-Executive Director, Board of Directors
View full ADC Therapeutics profile